Pillai N P, Bhargava H N
Pharmacol Biochem Behav. 1984 Sep;21(3):365-8. doi: 10.1016/s0091-3057(84)80096-9.
The effects of prolyl-leucyl-glycinamide (MIF) and naloxone on the gastrointestinal transit in mice were investigated using the charcoal meal test. MIF administered intraperitoneally (IP) (1-10 mg/kg) or intracerebroventricularly (ICV) (10 micrograms/mouse) had no effect on the transit. Administration of morphine by subcutaneous (SC) route significantly inhibited the gastrointestinal transit. The morphine-induced inhibition of the transit was not affected by MIF whether given by IP or ICV route. Administration of the opiate antagonist naloxone (1 mg/kg, IP or 10 micrograms/mouse, ICV) had no effect on the gastrointestinal transit, but it significantly antagonized the inhibition produced by morphine. Some earlier studies have indicated narcotic antagonistic effect of MIF. However, in the present study, evidence for such an action of MIF was not obtained. It is suggested that MIF does not appear to have narcotic antagonistic activity and further supports an earlier study from this laboratory that MIF may not interact with opiate receptors.
采用炭末试验研究了脯氨酰 - 亮氨酰 - 甘氨酰胺(MIF)和纳洛酮对小鼠胃肠转运的影响。腹腔注射(IP)(1 - 10毫克/千克)或脑室内注射(ICV)(10微克/只)MIF对胃肠转运无影响。皮下(SC)注射吗啡显著抑制胃肠转运。无论IP或ICV途径给予MIF,均不影响吗啡诱导的胃肠转运抑制作用。给予阿片拮抗剂纳洛酮(1毫克/千克,IP或10微克/只,ICV)对胃肠转运无影响,但能显著拮抗吗啡产生的抑制作用。一些早期研究表明MIF具有麻醉拮抗作用。然而,在本研究中,未获得MIF有此类作用的证据。提示MIF似乎不具有麻醉拮抗活性,进一步支持了本实验室早期的一项研究,即MIF可能不与阿片受体相互作用。